Post-Hemorrhoidectomy Daflon Administration
Yes, Daflon (micronized purified flavonoid fraction) should be given after hemorrhoidectomy as it significantly reduces postoperative bleeding, pain, and accelerates recovery.
Evidence-Based Recommendation
The use of Daflon post-hemorrhoidectomy is supported by multiple high-quality randomized controlled trials demonstrating meaningful clinical benefits:
Primary Benefits
Bleeding Reduction: The most compelling evidence comes from a prospective randomized controlled trial showing that only 0.9% of patients receiving Daflon 500 mg for 1 week post-hemorrhoidectomy experienced secondary bleeding, compared to 6.1% in the control group (P = 0.03) 1. All bleeding episodes occurred between days 6-15 postoperatively, precisely when Daflon provides protection.
Pain Control: A randomized controlled study of 112 patients demonstrated that Daflon significantly reduced pain scores on postoperative days 2 and 3 (P = 0.033 and P = 0.011), decreased the need for intramuscular analgesic injections (P = 0.022 and P = 0.007), shortened hospital stay, and improved patient satisfaction (both P = 0.001) 2. By one week, pain scores and analgesic requirements remained significantly lower in the Daflon group.
Symptom Resolution: A 2024 randomized trial of 135 patients found that while the first 3 postoperative days showed no difference, by days 7,21,40, and 60, patients receiving micronized flavonoid fraction had statistically significant reductions in pain, bleeding, and tenesmus compared to controls 3.
Dosing Protocol
Based on the clinical trial evidence:
- Standard regimen: Daflon 500 mg twice daily for 1 week post-hemorrhoidectomy 1
- Extended regimen: Can be continued for up to 60 days for persistent symptoms 3
- Acute phase: Some protocols use 3 tablets twice daily for 4 days, then 2 tablets twice daily for 3 days 4
Mechanism of Action
Daflon works through multiple pathways relevant to post-hemorrhoidectomy recovery:
- Increases venous tone and reduces venous stasis
- Improves lymphatic drainage to reduce edema
- Protects microcirculation from inflammatory processes
- Reduces capillary hyperpermeability
- Provides anti-inflammatory effects 4, 5
Safety Profile
No adverse effects were reported in the hemorrhoidectomy trials 1. The medication has a tolerability profile similar to placebo, with the most common side effects being mild gastrointestinal symptoms 4. No cases of intolerance were identified in the 220-patient observational study 5.
Important Caveats
FDA Status: Note that micronized purified flavonoid fraction (MPFF/Daflon) has not been approved by the FDA for use in the United States 6. However, it is widely used internationally and included in treatment guidelines in other countries.
Guideline Context: While the 2004 AGA guidelines mention MPFF studies showing symptomatic improvement for hemorrhoidal bleeding, they primarily discuss its use for medical management of hemorrhoids rather than specifically endorsing post-hemorrhoidectomy use 6. The surgical guidelines focus on operative techniques and pain management strategies but do not explicitly recommend or contraindicate Daflon 6, 7.
Not a Substitute: Daflon is an adjunct therapy and does not replace standard postoperative care including adequate analgesia, stool softeners, and proper wound care.
Clinical Bottom Line
The evidence strongly supports routine administration of Daflon after hemorrhoidectomy to reduce the two most significant postoperative complications—bleeding and pain—while improving overall recovery and patient satisfaction. The medication is safe, well-tolerated, and provides measurable benefits across multiple outcome measures that directly impact patient morbidity and quality of life.